Skip Navigation LinksHome > January 2001 - Volume 321 - Issue 1 > α1-Antitrypsin Deficiency:: Biological Answers to Clinical Q...
American Journal of the Medical Sciences:
Symposium

α1-Antitrypsin Deficiency:: Biological Answers to Clinical Questions

Coakley, Raymond J. MD; Taggart, Clifford PhD; O’Neill, Shane MD; McElvaney, Noel G. MD

Collapse Box

Abstract

α1-antitrypsin (α1AT) deficiency is a common lethal hereditary disorder of white persons of European descent. The condition is characterized by reduced serum levels of α1AT, a 52-kDa glycoprotein synthesized chiefly in the liver and, to a lesser extent, by macrophages and neutrophils. α1AT acts as an antiprotease and is the physiological inhibitor of neutrophil serine proteases such as neutrophil elastase cathepsin G and proteinase 3. The clinical manifestations of α1AT deficiency occur chiefly in the lung, with a high risk of emphysema occurring by the third or fourth decade of life. Cigarette smoking accelerates the development of emphysema in persons with α1AT deficiency. There is also an increased risk of liver disease in α1AT deficiency, which occurs mostly in childhood. In this review, we will define further the diagnosis of α1AT deficiency and its clinical manifestations and describe the therapeutic strategies that are currently being developed to treat the hepatic and pulmonary disease associated with this condition.

© Copyright 2001 Southern Society for Clinical Investigation

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.